Abstract
Due to an error during production, some in-text and most of the in-table citations were not correctly displayed in the original previous online version of the article and have now been corrected. The original article has been corrected.
| Original language | English |
|---|---|
| Pages (from-to) | 465 |
| Number of pages | 1 |
| Journal | European Journal of Clinical Pharmacology |
| Volume | 77 |
| Issue number | 4 |
| Early online date | 15 Dec 2020 |
| DOIs |
|
| Publication status | Published - Apr 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Targeted antineoplastic drugs
- Tyrosine kinase inhibitors
- Therapeutic drug monitoring
- Oral anticancer drugs
- Personalised medicine
Fingerprint
Dive into the research topics of 'Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs (European Journal of Clinical Pharmacology, (2021), 77, 4, (441-464), 10.1007/s00228-020-03014-8)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver